Karyopharm Therapeutics
KPTI
#8730
Rank
HK$1.41 B
Marketcap
HK$62.66
Share price
-1.96%
Change (1 day)
90.94%
Change (1 year)

Market capitalization of Karyopharm Therapeutics (KPTI)

Market cap: HK$1.41 Billion

As of April 2026 Karyopharm Therapeutics has a market cap of HK$1.41 Billion. This makes Karyopharm Therapeutics the world's 8730th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Karyopharm Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$1.41 B43.1%
2025HK$0.98 B43.72%
2024HK$0.68 B-11.24%
2023HK$0.77 B-74.27%
2022HK$3.00 B-20.6%
2021HK$3.78 B-57.11%
2020HK$8.83 B-9.5%
2019HK$9.75 B118.66%
2018HK$4.46 B26.13%
2017HK$3.53 B17.71%
2016HK$3.00 B-18.38%
2015HK$3.68 B-61.2%
2014HK$9.49 B80.53%
2013HK$5.25 B

End of Day market cap according to different sources

On Apr 9th, 2026 the market cap of Karyopharm Therapeutics was reported to be:

HK$1.17 Billion
by Nasdaq info icon info icon
HK$1.44 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Abbott Laboratories
ABT
HK$1.383 T 97,861.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$2.359 T 166,945.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$945.04 B 66,808.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$93.89 B 6,547.56%๐Ÿ‡บ๐Ÿ‡ธ USA